UK +44 (0)1865 849841
Malaysia +60 3 2117 5193
  • The Big List of Microbiome Companies and Investors

    Here we’ve compiled a list of 119 microbiome companies, investors and dates active. Whether you’re just curious or are looking for an investor from seed to series, you’re sure to find something useful.

  • 5 Lessons Learned From Transitioning to Digital

    Liron Pantanowitz, Professor of Pathology and Biomedical Informatics, Director of Pathology Informatics at the University of Pittsburgh Medical Center, talks about what they learned during their transition to digital.

  • Probiotics: Market Trends and Opportunities 2017

    At the Probiotics Congress in Amsterdam, Maria Saarela presented ‘Recent Developments in Probiotic Research and the Market’. Some of the key market trends examined in Maria Saarela’s talk are summarised here.

  • Generating a Library of Orthogonal Genetic Switches

    Georg Fritz is an Independent Group Leader at the LOEWE Center for Synthetic Microbiology, Philipps-University Marburg. We caught up with Georg ahead of 4Bio.

  • How to Avoid Unnecessary Data Loss in qPCR Reactions

    Jan M Ruijter is a medical biologist with experience in endocrinology, neurobiology, ophthalmology and embryology. In this blog, he outlines how he avoids unnecessary data loss in qPCR reactions.

Probiotic Consortia Applications In Non-Sterile Soil

Plants feed microbial communities that, in return, provide the plant with growth hormones and antibiotics. Alexandre Jousset’s research focuses on probiotics consortia in tomato plant roots that form a shield defending plant tissues from Ralstonia solanacearum (Wei et al., 2015). This is an aerobic non-spore forming plant pathogenic bacterium colonising the xylem and causing bacterial wilt in its host. It can affect most world crop species including tomato, potato, banana and tobacco and there’s still no cure for this disease (Hu et al., 2016).

Read More

How to implement machine learning to reap true advantages in pathology

Digitization paves the way for machine learning

With the first FDA approval for primary diagnosis now being a fact, together with several European labs performing the majority of their review digitally, the digitization of pathology has sped up and is now in many labs’ plans.

Read More

Probiotic Foods and Supplements: An Open Letter From Paul Cotter

Dear Colleagues,

Fermentation, commonly used to preserve foods, has become the latest “gut health” phenomenon. Fermented foods contain an array of microorganisms which have the potential to confer health benefits to individuals that ingest them. In fact, there are several fermented beverages and foods currently on the market purported to be health-promoting; not all of which are equally beneficial.

Read More

The Big List of Synthetic Biology Companies and Investors

2013 saw a dramatic increase in synthetic biology investment: a trend which continues year-on-year. In 2016 there were 8x more investments than in 2005 and having already surpassed 2016’s numbers, 2017 is set to be the biggest yet.

Read More

Defining the Microbiome Opportunity

One of the first challenges we encounter when considering the ‘Microbiome Opportunity’ is to describe exactly what we mean by it. Here, we visualize the opportunity as a multidimensional space that organizes itself along multiple axes.

Read More

The Wheat Genome Sequence Odyssey

As the world population is expected to reach 9.8 billion by 2050, it is crucial to have innovative genomics tools to address global food security in a sustainable way.

Read More

Is the age of invention over?

At the dawn of the last century, people who were heralded as world-changers were a different breed. Edison, Franklin (and let’s also put Tesla here, though his contributions weren’t recognized at the time), Turing, Neumann, and a lot of other great people. Things are different now. The people we idolize today are the innovators – Jobs, Musk, Page&Brin – the Great Communicators who can drive products to the market, and carve out a viable market strategy despite the strong competition, or create entirely new markets.

Read More

Biofuels; The Energy Resource Of Our Future

Norman Lewis’ research currently focuses on the composition of phenylpropanoid metabolism pathway, which provides plants with neolignans and lignans. These are organic compounds giving structure and rigidity to the cell wall and allowing the normal growth and developments of plants. We interviewed him about his research.

Read More

How to implement machine learning to reap true advantages in pathology

Digitization paves the way for machine learning

With the first FDA approval for primary diagnosis now being a fact, together with several European labs performing the majority of their review digitally, the digitization of pathology has sped up and is now in many labs’ plans.

Read More

Probiotic Foods and Supplements: An Open Letter From Paul Cotter

Dear Colleagues,

Fermentation, commonly used to preserve foods, has become the latest “gut health” phenomenon. Fermented foods contain an array of microorganisms which have the potential to confer health benefits to individuals that ingest them. In fact, there are several fermented beverages and foods currently on the market purported to be health-promoting; not all of which are equally beneficial.

Read More

The Big List of Synthetic Biology Companies and Investors

2013 saw a dramatic increase in synthetic biology investment: a trend which continues year-on-year. In 2016 there were 8x more investments than in 2005 and having already surpassed 2016’s numbers, 2017 is set to be the biggest yet.

Read More

Defining the Microbiome Opportunity

One of the first challenges we encounter when considering the ‘Microbiome Opportunity’ is to describe exactly what we mean by it. Here, we visualize the opportunity as a multidimensional space that organizes itself along multiple axes.

Read More

Is the age of invention over?

At the dawn of the last century, people who were heralded as world-changers were a different breed. Edison, Franklin (and let’s also put Tesla here, though his contributions weren’t recognized at the time), Turing, Neumann, and a lot of other great people. Things are different now. The people we idolize today are the innovators – Jobs, Musk, Page&Brin – the Great Communicators who can drive products to the market, and carve out a viable market strategy despite the strong competition, or create entirely new markets.

Read More

Probiotics: Market Trends and Opportunities 2017

Google search volume for the term ‘probiotics’ from 2004 – 2016. Data source: Google Trends

Microbiota has been associated with almost all aspects of human health and disease. Subsequently, the potential applications of probiotics broadened. However, health claim regulation has had a major impact on the probiotic market, particularly in the EU.

Read More

5 lessons learned from transitioning to digital

This article was originally published by The Pathologist, November 2016,  and is published with permission.

Digital pathology is not just about the tech. You have to consider the practical impact that technology has on the people who use and maintain it, and on how it affects their day-to-day work.

Read More

Generating a Library of Orthogonal Genetic Switches

Image credit: Fdardel, Wikimedia Commons, licensed under CC BY-SA 3.0

Georg Fritz is an Independent Group Leader at the LOEWE Center for Synthetic Microbiology, Philipps-University Marburg. We caught up with Georg ahead of 4Bio.

Read More

Probiotic Consortia Applications In Non-Sterile Soil

Plants feed microbial communities that, in return, provide the plant with growth hormones and antibiotics. Alexandre Jousset’s research focuses on probiotics consortia in tomato plant roots that form a shield defending plant tissues from Ralstonia solanacearum (Wei et al., 2015). This is an aerobic non-spore forming plant pathogenic bacterium colonising the xylem and causing bacterial wilt in its host. It can affect most world crop species including tomato, potato, banana and tobacco and there’s still no cure for this disease (Hu et al., 2016).

Read More

The Wheat Genome Sequence Odyssey

As the world population is expected to reach 9.8 billion by 2050, it is crucial to have innovative genomics tools to address global food security in a sustainable way.

Read More

Biofuels; The Energy Resource Of Our Future

Norman Lewis’ research currently focuses on the composition of phenylpropanoid metabolism pathway, which provides plants with neolignans and lignans. These are organic compounds giving structure and rigidity to the cell wall and allowing the normal growth and developments of plants. We interviewed him about his research.

Read More

The Synergistic Relationship Between University and Industry: A Case Study

All companies look to universities for the training and expertise of their future workforce. Yet, many companies have discovered that relationships with universities can yield much more than access to future staff members.

Read More

The Global Biocontrol & Biostimulants Congress Presentation Slides

Experts in plant science examined the latest advances in biologicals technique and the future of their industry. We made some of their presentation slides available for you to download.

Read More

CRISPR: From Early Discoveries to Applications in Plant Science

The discovery of CRISPR happened by accident in 1987. First applied in mammalian cells in 2013, a year later it was applied to plant cells. Our timeline highlights the milestones of this novel technology until its most recent developments and applications in plant science.

Read More

Potential Investments in Plant Microbiome

Among the topics covered during the panel discussion at the 5th Plant Genomics and Gene Editing Congress: Europe was the present and future investments of microbiome within the European market.

Read More

Report: Developing Biopesticides For Distribution

The application of crop biotechnology in agriculture has permitted an enhanced level of income to farmers and environmental benefits, while also reducing cropland expansion.

Read More

Challenges in Printing Hybrid Light Emitting Diodes

Organic Light Emitting Diodes (OLEDs)

Organic Light Emitting Diodes (OLEDs) are sub-micrometric devices formed by multi-stacked materials that have reached the appropriate Technological Readiness Level to be present in displays. Intense research has permitted the construction of diodes with long lifetimes, multi-colour emission and size variety.

Read More

Enabling Flexible Displays and Sensors With Organic Electronics

While most conventional electronics are based on silicon transistors, there are other approaches being developed that seek to enable truly flexible components. At FlexEnable we believe the only way you can make truly flexible electronics is to start with truly flexible materials, so we use plastics (also referred to as organic materials) instead of ceramics to make our transistors.

Read More

E-waste Recycling and Repurposing

Electronic waste (e-waste) is a fast growing problem. The UN estimates between 20-50 million tons of electronic waste is discarded every year, with only 12.5% of this being recycled. This leaves a colossal amount of e-waste sitting in landfill or improperly disposed of, which in turn leads to toxic materials leaching into the soil and water supply.

Read More

Printed and Flexible Electronics: An Open Letter From Ton van Mol

Here at the Holst Centre, our technologies have matured in the last few years and our focus has expanded. We concentrate on application driven research, such as wearable health, automotive, the Internet of Things and solar energy.

Read More

From Liquid Crystal Displays in 1996 to Microfluidics in 2016

Emmanuel Delamarche is a researcher at IBM Research who presented at our 2nd Microfluidics Congress about his research on precision diagnostics based on modular capillary-driven elements.

Read More

Subscribe to Our Newsletter

Get free reports and resources from our world class speakers.
  • This field is for validation purposes and should be left unchanged.

Life Sciences Twitter Feed

Archive